Clément Triaille, Kevin Côté, Jérôme Coulombe, Maité Daroux, Clémence David, Marie-Louise Frémond, Elie Haddad, Naseer Khan, Victor Kokta, Anne-Laure Lapeyraque, Céline Lebas, María Luisa Matoses Ruipérez, Berta López Montesinos, Héloise Reumaux, Tiphanie P Vogel, Marie-Paule Morin, Véronique Phan
{"title":"Kidney Transplant Outcomes in Coatomer Protein Complex Subunit Alpha (COPA) Syndrome: Report of Five Patients.","authors":"Clément Triaille, Kevin Côté, Jérôme Coulombe, Maité Daroux, Clémence David, Marie-Louise Frémond, Elie Haddad, Naseer Khan, Victor Kokta, Anne-Laure Lapeyraque, Céline Lebas, María Luisa Matoses Ruipérez, Berta López Montesinos, Héloise Reumaux, Tiphanie P Vogel, Marie-Paule Morin, Véronique Phan","doi":"10.1053/j.ajkd.2025.12.007","DOIUrl":null,"url":null,"abstract":"<p><p>COPA (coatomer protein complex subunit α) syndrome is a rare inborn error of immunity associated with constitutive activation of type I interferon signaling. Organ inflammation and damage (i.e. lungs, kidneys, joints) usually develops early in life. Kidney involvement occurs in a subset of COPA syndrome patients, with the potential for rapid progression to kidney failure. Through an international collaboration, we identified COPA syndrome patients who developed kidney failure and underwent a kidney transplantation. The aim of the present report was to describe (i) the kidney involvement at presentation, (ii) the immunosuppressive strategies used before and after transplant, (iii) the kidney graft outcomes, and (iv) the evolution of the underlying COPA disease after transplantation. Five COPA syndrome patients were included. Kidney failure manifested at young age (range: 5 - 40 years). Kidney involvement was heterogenous between patients (ANCA-associated vasculitis-like disease, lupus or immune-complex mediated glomerulonephritis or overlapping phenotypes), and all had advanced histological damage at clinical presentation. Pulmonary disease of variable severity was also present in all patients. Kidney disease responded poorly to multiple lines of immunosuppression justifying kidney transplantation between the ages of 7.5 and 42 years. After a follow-up of 10 months-12 years, we report favorable graft outcomes in all patients (CKD stage 2-3b) but one patient developed polyomavirus infection (skin, kidney graft), and another died of progressive lung disease.</p>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1053/j.ajkd.2025.12.007","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
COPA (coatomer protein complex subunit α) syndrome is a rare inborn error of immunity associated with constitutive activation of type I interferon signaling. Organ inflammation and damage (i.e. lungs, kidneys, joints) usually develops early in life. Kidney involvement occurs in a subset of COPA syndrome patients, with the potential for rapid progression to kidney failure. Through an international collaboration, we identified COPA syndrome patients who developed kidney failure and underwent a kidney transplantation. The aim of the present report was to describe (i) the kidney involvement at presentation, (ii) the immunosuppressive strategies used before and after transplant, (iii) the kidney graft outcomes, and (iv) the evolution of the underlying COPA disease after transplantation. Five COPA syndrome patients were included. Kidney failure manifested at young age (range: 5 - 40 years). Kidney involvement was heterogenous between patients (ANCA-associated vasculitis-like disease, lupus or immune-complex mediated glomerulonephritis or overlapping phenotypes), and all had advanced histological damage at clinical presentation. Pulmonary disease of variable severity was also present in all patients. Kidney disease responded poorly to multiple lines of immunosuppression justifying kidney transplantation between the ages of 7.5 and 42 years. After a follow-up of 10 months-12 years, we report favorable graft outcomes in all patients (CKD stage 2-3b) but one patient developed polyomavirus infection (skin, kidney graft), and another died of progressive lung disease.
期刊介绍:
The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.